ELVIRA
ACEBO MARIÑAS
PROFESORADO ASOCIADO
![Foto de Pablo Luis](/img/nophoto.png)
Pablo Luis
Ortiz Romero
Publicaciones en las que colabora con Pablo Luis Ortiz Romero (6)
2023
-
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64
-
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298
2021
-
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology
2020
-
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538
2018
-
The First Year of the AEVD Primary Cutaneous Lymphoma Registry
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 610-616
2012
-
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
British Journal of Dermatology, Vol. 167, Núm. 1, pp. 174-179